Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
2013 ◽
Vol 43
(2)
◽
pp. 365-374
◽
2014 ◽
Vol 55
(4)
◽
pp. 622-628
◽
2010 ◽
Keyword(s):
Keyword(s):
2013 ◽
2010 ◽
Vol 38
(9)
◽
pp. 1436-1442
◽